CDC: v-safe Now Available in Multiple Languages

Vaccine safety continues to be a top priority at CDC as COVID-19 vaccines are authorized or approved and recommended for use. CDC relies on several systems to monitor vaccine safety including v-safe, a new, smartphone-based tool.

You may already be familiar with v-safe, which uses text messaging and web surveys to provide personalized health check-ins after someone receives a COVID-19 vaccination. V-safe allows participants to reportsideeffects after COVID-19 vaccination to CDC in almost real-time. It also gives them a convenient reminder to get their second COVID-19 vaccine dose if they need one. 

We are happy to announce that v-safe is now available in the following languages:

  • English
  • Korean
  • Simplified Chinese
  • Spanish
  • Vietnamese

V-safe participants will receive text messages and web surveys in the language chosen when they sign-up.

V-safe webpages are also available in the above languages. To access these pages, go to Then, scroll to the bottom of your screen and select your language of choice.

Please share the following materials with your partners:

  • V-safe website in the above-mentioned languages
  • V-safe information sheet in the above-mentioned languages
  • V-safe poster in the above mentioned languages
  • Social media messages (attached to this email)
  • Key messages and FAQs for v-safe (attached to this email)

What can you do?  

  • Talk to community leaders, healthcare providers, and your other community partners about the availability of v-safe infive languages and encourage them to promote its use.
  • Distribute the v-safe information sheet and other materials in needed languages to your partners.
  • Share the provided social media messages and the v-safe promotional video on your social media channels.

With your help, we hope to enroll as many people into v-safe as possible and keep COVID-19 vaccination safe for everyone. Thank you again for your continued partnership and for your tireless work during the COVID-19 pandemic.


COVID-19 Vaccine Evaluation Communications Team

Vaccine Task Force

2019 Novel Coronavirus Response